What We're Reading: Page 118
Industry reads hand-picked by our editors
Apr 13, 2022
-
MobiHealthNews
Study: AI models need thorough preclinical testing to root out safety concerns
-
Bloomberg
Apple Targets Watch Blood-Pressure Tool for 2024 After Snags
-
SC Magazine
5 critical zero-days found in Aethon TUG smart robots used in global hospitals
-
Fast Company
This $1 COVID test could make going out again a breeze
Apr 12, 2022
-
CNN
With fewer cases and less demand, many Covid-19 testing sites are shutting down
-
STAT
Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules
-
Associated Press
Efforts to make protective medical gear in US falling flat
-
MedCity News
CMS is prioritizing healing heart valves over bolstering brain health
Apr 11, 2022
-
The New York Times
An uptick in U.S. virus cases is concerning but not surprising, Fauci says
-
Wall Street Journal
Covid-19 Tests Are Easier to Find. Covering Their Cost Is Getting More Complicated.
-
TechCrunch
Fitbit gets FDA approval for AFib detecting algorithm
-
TCTMD
BIO|GUARD-MI: Post-MI Arrhythmia Monitoring Falls Short
Apr 08, 2022
Apr 07, 2022
-
Vox
America needs more doctors and nurses to survive the next pandemic
-
Kaiser Health News
A Shortfall of ECMO Treatment Cost Lives During the Delta Surge
-
MedPage Today
Which Drug-Coated Balloon Proved Superior in Peripheral Artery Disease?
-
MobiHealthNews
Aidoc software receives FDA green light for flagging, triaging brain aneurysms
Apr 06, 2022
-
Kaiser Health News
The End of the Covid Emergency Could Mean a Huge Loss of Health Insurance
-
STAT
Virtual reality in medicine is garnering more investment. Will the health care system buy in?
-
Evaluate Vantage
Embecta seeks high growth with low tech
-
The Verge
First autonomous X-ray-analyzing AI is cleared in the EU
Apr 05, 2022
-
Wall Street Journal
Congressional Negotiators Settle on $10 Billion for Covid-19 Tests, Treatments
-
The New York Times
Do Home Covid Tests Expire?
-
MedPage Today
Transcatheter Tricuspid Repair Shows Early Promise
-
Evaluate Vantage
Medicare’s new devices
Previous
